CanCHEW Bio-Technologies, a Medical Marijuana Inc. Product, Dr. George Anastassov Appeared on Small Cap Voice Internet Radio Program To Discuss The CanCHEW Advantage
Segments Aired and Now Fully Archived
SAN DIEGO, Aug. 8, 2012 /PRNewswire/ -- Medical Marijuana Inc. (OTC: MJNA) a leading hemp industry innovator, is pleased to announce that Company Director of CanChew Biotechnologies Inc. Dr George E. Anastassov has recently appeared on Small Cap Voice's internet radio network.
Dr. Anastassov Interview Archived
The interview, conducted by Small Cap Voice internet radio host, Stuart T. Smith gave a good insight into the history of CanChew Biotechnologies and Dr. Anastassov's participation in the development of the revolutionary new product. CanChew's new high concentration hemp based CBD-infused chewing gum is expected for soft release on September 15th in United States, with international markets to soon follow suit.
The interview can be found via the following link: Interview
Initially being released on the over-the-counter market as a health and wellness product, CanChew gum is undergoing clinical development in the European Union for pain relief, relief for muscular spasticity, particularly in MS patients as well as relief from Nausea, specifically from chemotherapy. The key active ingredient, the hemp-based CBD-infused essential oil is made available by Medical Marijuana Inc and their state-of-the-art extraction technology.
During the interview, Dr. Anastassov touched on some of the challenges facing present day prescription pain medications and the need, especially in Europe, for safe but effective pain relief options and how the CanChew advantages aims to bridge that gap.
CanChew® is a unique, socially acceptable, patient friendly, taste masked and convenient delivery format for delivery of cannabis/cannabinoid(s) based pharmaceuticals. The delivery of these medications via the oral mucosa provides for rapid and near complete absorption directly into the systemic circulation. This leads to rapid onset of effects and increased bioavailability. Pre-systemic metabolism is thus avoided. This system of delivery offers clearly improved economic opportunities compared to alternative drug delivery routes.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.
Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.
For more information, please visit the company's website at: www.MedicalMarijuanaInc.com
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
Investor Relations Contact:
Stuart T. Smith
SOURCE Medical Marijuana Inc.
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.